|
|
|
|
| Instructions: Complete this post-video evaluation and correctly answer at least fifteen of the 25 post-test questions. We will provide rationale for questions not answered correctly. You may repeat the course up to three times to pass. Your certificate will be emailed to you within two weeks of documentation of successful completion. A copy of the post-test questions with correct answers will be provided. All information is kept confidential and used for education purposes only.
|
|
|
|
|
| 1. Which trio of chemists first named cannabinol (CBN) while analyzing cannabis red oil?
|
|
|
|
|
|
|
| 2. What structural feature differentiates Delta-8-THC from Delta-9-THC?
|
|
|
|
|
|
|
| 3. What parent molecule gives rise to the major acidic cannabinoids THCA, CBDA, and CBCA in the plant?
|
|
|
|
|
|
|
| 4. Which scientist is credited with establishing the modern structure of Delta-9-THC (1964)?
|
|
|
|
|
|
|
| 5. THCP differs from THC primarily because it has:
|
|
|
|
|
|
|
| 6. Which cannabinoid is considered the dehydrogenated degradation product of THC found in older plant material?
|
|
|
|
|
|
|
| 7. The Farm Bill of 2018 created a legal loophole that enabled widespread production of which hemp-derived cannabinoid?
|
|
|
|
|
|
|
| 8. The first pass metabolism of orally ingested THC forms a metabolite that is more psychoactive than THC. Which metabolite is it?
|
|
|
|
|
|
|
| 9. Which of the following is TRUE about CBD?
|
|
|
|
|
| 10. Synthetic cannabinoids such as JWH-018 (K2) and JWH-073 (Spice) are classified as:
|
|
|
|
|
| 11. Which Ohio entity currently has primary authority to license and regulate both medical and adult-use cannabis operations?
|
|
|
|
|
| 12. Which function remains under the exclusive jurisdiction of the State Medical Board of Ohio?
|
|
|
|
|
| 13. What trend was observed in Ohio’s medical cannabis patient registrations after adult-use legalization?
|
|
|
|
|
| 14. Which of the following best explains why Ohio dispensaries are described as “dual-use”?
|
|
|
|
|
| 15. Which accommodation is dispensary licensees required to provide for medical cannabis patients?
|
|
|
|
|
| 16. What was identified as the most common compliance issue for CTR physicians?
|
|
|
|
|
| 17. Which statement regarding telehealth for CTR visits in Ohio is correct?
|
|
|
|
|
| 18. Which of the following is a key reason the Division of Cannabis Control prioritizes product testing?
|
|
|
|
|
| 19. What major safety concern was raised about hemp-derived products such as delta-8 THC sold outside dispensaries?
|
|
|
|
|
| 20. What role does a Certificate of Analysis (CoA) serve for cannabis products?
|
|
|
|
|
| 21. Which of the following is an advantage of remaining in Ohio’s medical cannabis program?
|
|
|
|
|
| 22. Which statement best reflects Ohio law regarding cannabis and employment?
|
|
|
|
|
| 23. What is the statutory timeframe for the State Medical Board to issue a decision on a petition for a new qualifying condition?
|
|
|
|
|
| 24. Why is it important for CTR physicians to maintain independent medical records separate from the state registry?
|
|
|
|
|
| 25. Which recent Ohio legislation aligned state law with federal restrictions on intoxicating hemp-derived THC products?
|
|
|
|
|
| 26. Describe at least one change you will make in your practice as a result of this new information.
|
|
|
|
|
|
|
| OVERALL (Scale: Strongly agree / Agree / Do not agree)
|
| 1. I am satisfied with the webinar format
|
| 2. I am satisfied with the registration process
|
| 3. The content added to my overall knowledge
|
| 4. Overall the webinar addressed what I hoped to learn
|
| 5. What other questions do you have about medical marijuana?
|
|
|
| 6. What has changed for you after hearing this information?
|
|
|
| 7. Comments?
|
|
|
|
|
|
|
|
|
| Required to process your CME certificate:
|
| First Name | |
| Last Name | |
| Credentials (MD, DO, MPH, FACS, etc.) | |
| Organization/Company/Practice Name | |
| Email Address | |
| CTR status | |
